chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chest pain, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 22-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 11May2021 10:30 (at the age of 22-year-old) as dose 1, single for covid-19 immunisation. The patient medical history included none and concomitant medications were not reported. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported as other vaccine second dose was administered in left arm on 11May2021. On 12May2021, the patient experienced fever, fatigue, pain and swelling at the injection site, chest pain. The patient underwent lab tests and procedures which included body temperature: unknown on 12May2021. No treatment was taken as a result of events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; Fever, fatigue, pain and swelling at the injection site, chest pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 22-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 11May2021 10:30 (at the age of 22-year-old) as dose 1, single for covid-19 immunisation. The patient medical history included none and concomitant medications were not reported. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported as other vaccine second dose was administered in left arm on 11May2021. On 12May2021, the patient experienced fever, fatigue, pain and swelling at the injection site, chest pain. The patient underwent lab tests and procedures which included body temperature: unknown on 12May2021. No treatment was taken as a result of events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Night sweats, Vomiting
Clinical narrative: After the second dose, same symptoms (night sweats, chills, vomiting); After the second dose, same symptoms (night sweats, chills, vomiting); After the second dose, same symptoms (night sweats, chills, vomiting), still vomiting at 4 days post-vaccine; Night Sweats, Chills, Vomiting. After first dose; Night Sweats, Chills, Vomiting. After first dose; Night Sweats, Chills, Vomiting. After first dose; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 18Apr2021 (at the age of 16-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EUU0173) via an unspecified route of administration in the left arm on 08May2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO) taken for an unspecified indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 19:00, after the first dose, the patient experienced night sweats, chills, vomiting and the symptoms had lasted for 4 days. On an unknown date in May2021, after the second dose, the patient experienced the same symptoms (night sweats, chills and vomiting); vomiting continued at 4 days post-vaccine. The patient was able to hydrate, but could not keep food down yet. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. Following the first dose, the clinical outcome of the events night sweats, chills and vomiting were recovered on 22Apr2021. Following the second dose, the clinical outcome of the events night sweats and chills were unknown and vomiting was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Electric shock
Clinical narrative: Electrical shocks in different areas of body; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the right arm on 26Apr2021 at 09:45 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not take any concomitant medications. On 26Apr2021 at 13:00, the patient experienced electrical shocks in different areas of body. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event electrical shocks in different areas of body was resolved on an unknown date in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph nodes under left arm pit swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 11May2021 at 08:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 15:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 07:00, the patient experienced lymph nodes under left arm pit swollen. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event lymph nodes under left arm pit swollen was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes on both side of neck area close to collar bone; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 02Feb2021 at 13:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease (CKD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 04Feb2021 at 09:00, the patient experienced swollen lymph nodes on both side of her neck area close to her collar bone. It was reported that swollen lymph nodes were not there prior to the vaccination. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether therapeutic measures were taken as a result of the reported event. The clinical outcome of the event swollen lymph nodes on both side of neck area close to collar bone was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site inflammation, Vaccination site pain, Vaccination site warmth
Clinical narrative: Inflamed skin with increased temperature on the arm around the location of the injection; Affected area is tender to the touch; Inflamed skin with increased temperature on the arm around the location of the injection; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10May2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulitis, and osteoporosis and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 19Apr2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 11May2021 at 09:30 the patient experienced inflamed skin with increased temperature on the arm around the location of the injection and affected area was tender to the touch. The symptoms continued for three days after vaccine was administered.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events inflamed skin with increased temperature on the arm around the location of the injection and affected area was tender to the touch were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Vaginal haemorrhage
Clinical narrative: After dose 2, I have vaginal bleeding the day after.  Last period ended 8May, next period not due until 2Jun.; After dose 2, I have vaginal bleeding the day after.  Last period ended 8May, next period not due until 2Jun.; This is a spontaneous report from a contactable consumer or other non hcp. A 35-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date as dose 2, single for covid-19 immunisation. Medical history included type 2 diabetic. Patient had Mild allergy to asparagus (facial hives). Concomitant medications included insulin glargine (LANTUS); insulin lispro (HUMALOG). Patient did not receive any other vaccines in 4 weeks. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. Patient received previously first dose of vaccine and After dose one, her period arrived 8 days early. The patient experienced after dose 2, she has vaginal bleeding the day after. last period ended 8may, next period not due until 2jun. on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: Awoke to room spinning; Nausea with neck flexion; This is a spontaneous report from a contactable nurse, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 07May2021 at 12:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis and allergies to dried fruit preservatives. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient received unspecified concomitant medication. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 14Apr2021 at 12:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 09May2021 at 07:00, (also reported as 36 hours after dose), the patient awoke to room spinning in the morning (reported as AM) did not stop for 8 hours and the patient also experienced nausea with neck flexion and spinning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events awoke to room spinning and nausea with neck flexion was resolved on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea
Clinical narrative: Fatigue; Light headedness; Slight nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ascorbic acid (VITAMIN C) for unknown indication from unknown start date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021, 2 weeks after being fully vaccinated, the patient experienced fatigue, light headedness, and slight nausea. The patient was still experiencing these symptoms (at the time of reporting) also some days were good and she felt normal and other days not good. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, light headedness, and slight nausea were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Mild waves of dizziness/vertigo which is not constant.; Mild waves of dizziness/vertigo which is not constant.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 14Apr2021 at 11:00, as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the right arm on 08May2021 at 11:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced mild waves of dizziness/vertigo which was not constant. The patient experienced this with the first dose as well, but not as strong as second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild waves of dizziness/vertigo which was not constant was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Nausea; Headache; Fatigue; This is a spontaneous report from a contactable nurse, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via intramuscular route of administration in the left arm on 30Apr2021 at 15:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, ocular dysmetria, irritable bowel syndrome (IBS), all tapes (adhesive tape) allergy and sulfonamide allergy. Prior to the vaccination, it was unknown if the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included doxylamine succinate (UNISOM), nigella sativa (BLACK SEED OIL), ibuprofen (ADVIL), magnesium (MANUFACTURER UNKNOWN), fish oil (OMEGA 3), vitamin d nos (VIT D) and cyanocobalamin (VIT B12); all taken from an unknown date for an unknown indication and unknown if ongoing. The patient previously received cefprozil (MANUFACTURER UNKNOWN), levofloxacin (LEVAQUIN), doxycycline (MANUFACTURER UNKNOWN), angelica sinensis (DONG QUAI), cetrimonium bromide (ELASTOPLAST) and panax ginseng root (GINSENG) and experienced drug allergy. On 05May2021 at 06:00, the patient experienced nausea, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, headache and fatigue was recovered on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in the ear after 36 hours of vaccine; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 15:15 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within 2 weeks of the vaccination and other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 16:15 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. On 09May2021 at 07:00, the patient experienced ringing in the ear after 36 hours of vaccine. It was reported that on Sunday the patient got up with ringing in the ear. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in the ear after 36 hours of vaccine was not resolved at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Panic attack
Clinical narrative: Anxiety/panic attacks (4); Anxiety/panic attacks (4); This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient had no relevant medical history and no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 10Apr2021, the patient experienced anxiety/panic attacks (4) since second vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events anxiety/panic attacks (4) were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Vaccination site pain
Clinical narrative: Severe pain from shoulder to elbow at injection site; Sever pain from shoulder to elbow at injection site.; Sever pain from shoulder to elbow at injection site.; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 17:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 12May2021 at 20:00, the patient experienced severe pain from shoulder to elbow at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL). The clinical outcome of the events severe pain from shoulder to elbow at injection site were not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Condition aggravated
Clinical narrative: Seemingly random stomach cramping every couple of days. The patient diagnosed with IBS, but usually have symptoms under control, and diet has not changed recently was not resolved at the time of this report; Seemingly random stomach cramping every couple of days. The patient diagnosed with IBS, but usually have symptoms under control, and diet has not changed recently was not resolved at the time of this report.; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 27Apr2021 at 11:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS) and ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 01May2021, the patient experienced seemingly random stomach cramping which occurred every couple of days. The patient was diagnosed with IBS, but usually her symptoms under control, and diet was not changed recently. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event seemingly random stomach cramping every couple of days. The patient diagnosed with IBS, but usually have symptoms under control, and diet has not changed recently was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Hypoaesthesia, Swelling, Tenderness
Clinical narrative: Swelling and soreness/tenderness under right arm.; Swelling and soreness/tenderness under right arm; Swelling and soreness/tenderness under right arm; Numbness in right arm (elbow to hand); This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 10May2021 at 17:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 19Apr2021 at 04:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced swelling and soreness/tenderness under by right arm and numbness in right arm (elbow to hand). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling and soreness/tenderness under by right arm and numbness in right arm (elbow to hand) was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Constant migraine every day; This is a spontaneous report from a contactable other healthcare professional, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced constant migraine every day. The migraine resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of migraine and included treatment with steroids. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event constant migraine every day was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Fatigue, Pharyngeal swelling
Clinical narrative: Swelling of throat; shortness of breath; chest pain; extreme fatigue; This is a spontaneous report from a contactable consumer. A 22-year-old male patient (consumer) reported for himself that he received bnt162b2 (BNT162B2, formulation: Solution for injection, Batch/Lot Number: EW0179, expiration date not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 12May2021 13:15 (Age 22-years at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The historical vaccine included bnt162b2 (BNT162B2, Batch/Lot Number: EW0164, expiration date not reported), dose 1 (First Dose) via an unspecified route of administration, administered in Left Arm on 16Apr2021 at 03:00 PM (Age 22 years at the time of vaccination) as DOSE 1, SINGLE for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was School or Student Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. An hour after the shot, the patient developed swelling of throat and shortness of breath on 12May2021 at 2:30 PM. Now it was 4 days later, and the patient still had shortness of breath and chest pain as well as extreme fatigue that was developed on 12May2021 at 2:30 PM. The patient did not receive any treatment for the adverse events. The adverse event result in visit to an emergency room/department or urgent care (Non-serious). The outcome of the events was reported as not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL3247; Expiration date was not reported) on the left arm on 01Feb2021 (14:00) as dose 1, single, with route of administration unspecified, for COVID-19 immunization at the workplace clinic. Medical history included contrast dye allergy, and lime and cooked lemons allergy. The patient's concomitant medications were not reported.  The patient previously took morphine, and had drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. On an unspecified date in 2021, the patient had soreness at the injection site. The patient had received aspirin as treatment for the event. The outcome of the event was recovered on an unspecified date in 2021. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity
Clinical narrative: Metallic Taste; Soreness to arm; This is a spontaneous report from a contactable consumer (patient).   A 50-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in Deltoid Left on 13Jan2021 03:30, at the age of 50-years-old, (Lot Number: EK9231) as DOSE 2, SINGLE for covid-19 immunisation.  Medical history included Sjogren's syndrome from 20Oct2014 and ongoing, gallbladder abscess (gallbladder removed) in 1997. Historical vaccine includes dose 1 of BNT162B2 received on 23Dec2020, 03:30, (at the age of 49-years) Intramuscular on Left Deltoid, Lot number: E49899 in which the patient experienced Metallic taste, Sore arm, malaise, chills, and nausea. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL S) taken for Sjogren's syndrome from Oct2013; colestyramine (QUESTRAN) taken for gallbladder abscess from Nov1997; and paracetamol (TYLENOL 8 HOUR) taken for an unspecified indication from 04Jan2021 14:00.  On 13Jan2021 22:00, the patient experienced metallic taste and soreness to arm. The outcome of the events was recovered on 13Jan2021.  No treatment was received for the events.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Vaginal haemorrhage
Clinical narrative: My menstrual cycle has been significantly different since my vaccinations. I have bled on and off for 4-5 days at a time since Pfizer shot 2.; I have bled on and off for 4-5 days at a time since Pfizer shot 2; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 35-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0172), via an unspecified route of administration (at the age of 35-years), administered in arm left on 26Apr2021 at 12:00 as dose 2, single for COVID-19 immunization. Medical history included premenstrual dysphoric disorder (PMDD) from an unknown date and unknown if ongoing. Concomitant medications included citalopram hydrobromide (CELEXA [CITALOPRAM HYDROBROMIDE]) taken for an unspecified indication, start and stop date were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8732), via an unspecified route of administration (at the age of 35-years), administered in arm left on 05Apr2021 at 16:45 as dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 30Apr2021, since vaccination, the patient experienced my menstrual cycle has been significantly different since my vaccinations. I have bled on and off for 4-5 days at a time since Pfizer shot 2. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome for all the events was reported as not recovered.  Follow-up attempts completed. No further information expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Pruritus
Clinical narrative: Itching; Cramping in abdomen; Pain in hips; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 18Feb2021 at 15:20 (Batch/Lot Number: EN6200; Expiration Date: Jun2021) (at the age of 48-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in left arm (Batch/Lot Number: EL9265; Expiration date: May2021) (at the age of 48-years-old) on 28Jan2021 at 14:45 for COVID-19 immunisation and experienced chill (recovered), pain in hips (recovering) and pain in left ear (recovered); (the patient received no treatment for the events and did not require admission to the hospital). The patient experienced cramping in abdomen pain in hips  on 18Feb2021 and itching on an unspecified date. The patient received no treatment for events cramping in abdomen and pain in hips and did not require admission to hospital. The events did not require an emergency room visit. The patient visited an online to use televisit for events pain in hips and itching on 18Feb2021. The outcome of event cramping in abdomen was recovered on an unspecified date; outcome of event pain in hips was not recovered; and outcome of event itching was unknown. The patient did not undergo any relevant tests.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Alopecia, Fatigue, Flatulence, Hypoaesthesia
Clinical narrative: Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; Exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas; digestive and bowel issues, gas; This is a spontaneous report from a contactable Consumer. Female consumer (Patient) reported that:   A 68 years old non pregnant female patient received bnt162b2 (COVID 19 Pfizer brand, Formulation: Solution for injection, lot unknown reason was Unable to locate or read the details, Expiration date: unknown) via an unspecified route of administration on 28Mar2021 12:15 as dose number unknown, single for covid-19 immunisation at Pharmacy or Drug Store (age at the vaccination 68 years old). Medical history, concomitant medications were not reported and had no known allergies. The patient had not received other vaccine in four weeks and other medications in two weeks. On an unspecified date in 2021, the patient experienced exhaustion, hair loss, numbness in arms and feet, digestive and bowel issues, gas. The patient was not Covid prior vaccination and was not tested Covid post vaccination. Adverse event resulted in doctor or other healthcare professional office/clinic visit and received treatment with Celecox1B. Outcome of events were reported as not recovered.  Information on the Lot/batch number has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: mild jointaches; muscle aches; fatigue (minor); This is a spontaneous report from a contactable consumer (patient).   A 70-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 11Feb2021 07:45, at the age of 70-years-old, (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. It was unknown if the patient was pregnant at the time of vaccination.  The patient medical history included migraine. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication from 1981 and ongoing.  Historical vaccine includes dose 1 of bnt162b2 for covid-19 immunisation and experienced Sore arm and fatigue on 21Jan2021 7:45 and was fine now (no treatment received); and shingrix (manufacturer: GSK No. of previous doses 1 (2 total)) on 05Jan2021 and experienced Sore arm. The patient previously took Tylenol 250 mg (1/2 tablet) on 21Jan2021 for migraine (prior vaccination). On 11Feb2021, the patient experienced mild jointaches, muscle aches, and fatigue (minor). The outcome of the events was recovered after 36hours.  No treatment was received for the events.  No follow-up attempts are needed, information about batch number cannot be obtained.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Fatigue
Clinical narrative: He was really really tired Tuesday through Friday; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0177) as dose 1 single, administered in Deltoid Left on 24May2021 12:00 (at the age of 69-year-old) for COVID-19 immunization. Patient was diagnosed in 2011 or 2012 with antiphospholipid syndrome. The doctor that diagnosed him with Antiphospholipid syndrome earlier tested his blood, and the antibodies came back positive. He had surgery and was riding back and got a blood clot. An endocrinologist referred him and he found out he had antiphospholipid syndrome. The concomitant medications included apixaban (ELIQUIS) and testosterone (TESTOSTERONE). Because of patient condition, an auto immune disease that affects clotting, he takes Eliquis. Prior to vaccination patient did not have any vaccines within 4 weeks. The patient experienced he was really really tired on 25May2021. He was really tired Tuesday through Friday. His energy levels really came back on Saturday, 29May2021 and he felt chipper. Outcome of the vent was recovered on 28May2021.  Information on Lot/Batch number was available. Additional information has been requested.   Follow-up attempts are completed. No further information is expected.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspepsia, Fatigue, Headache
Clinical narrative: I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; I am 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headach; Throughout the day I experienced severe chest pain; At first I thought it may have been heartburn; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 15-years-old male patient received second dose of bnt162b2 (BNT162B2), Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 13Jun2021 at 15:00 (at the age of 15-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Facility type of vaccine was pharmacy or Drug Store. No, other vaccine in four weeks. None of other medications in two weeks. No, covid prior vaccination, no, covid tested post vaccination. No, known allergies. No, other medical history. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 23May2021 for COVID-19 immunisation. It was reported that on 14Jun2021 at 04:00, the patient experienced i am 15 years old, no side effects on the day of vaccination. woke up in the middle of the night with fever and chills. typical side effects occurred the following day (fever, fatigue, chills, headache, throughout the day patient experienced severe chest pain, at first patient thought it may have been heartburn. Therapeutic measures were taken as a result of, at first patient thought it may have been heartburn. Patient was 15 years old, no side effects on the day of vaccination. Woke up in the middle of the night with fever and chills. Typical side effects occurred the following day (fever, fatigue, chills, headache, etc) however throughout the day patient experienced severe chest pain. At first patient thought it may have been heartburn but after taking tums (antacid) the chest pain was not reduced in the slightest leading me to believe it could not have been heartburn. The pain was severe and could be described as the sensation of swallowing something too large however with a more painful and long lasting feeling. No, treatment for AE. The outcome of event was recovered.  Information on the Lot/batch number has been requested.